
|Podcasts|April 23, 2021
Podcast: First drug-eluting contact lens approved in Japan
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Advertisement
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses. This lens was recently approved in Japan for vision correction and allergy symptom relief. Brian Pall, OD, MS, FAAO, director of clinical science at Johnson & Johnson Vision Care, discusses the lens and its technology.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
"Do not dismiss these children": Dr Lotfi Merabet's message on CVI
2
Monthly pipeline update: August 2026
3
Beyond the tear film: The emerging role of periocular rehabilitation in comprehensive dry eye care
4
From Paper to Clinic, Episode 7: GLP-1s and idiopathic intracranial hypertension
5













